Last reviewed · How we verify
NCT01288625
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Phase 4 trial testing Amifostine in Oral Mucositis. Withdrawn.
Quick facts
| Lead sponsor | Sun Pharmaceutical Industries Limited |
|---|---|
| Phase | Phase 4 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
Drugs / interventions tested
- Amifostine (AMIFOSTINE) — full drug profile →
- Amifostine (AMIFOSTINE) — full drug profile →
Conditions studied
- Oral Mucositis — all drugs for Oral Mucositis →
- Stomatitis — all drugs for Stomatitis →
Sponsor
Sun Pharmaceutical Industries Limited — full company profile →
Who can join
Adults 18 to 70, any sex, with Oral Mucositis or Stomatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare the incidence of stomatitis when treating with amifostine before radiation treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01288625
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Amifostine
Trials testing the same drug.
- NCT03702985 — Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer · Phase 2 · unknown
- NCT01998529 — Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Chil · Phase 1 · completed
- NCT05167370 — High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid T · Phase 2 · terminated
- NCT00274937 — Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer · Phase 3 · completed
Other recruiting trials for Oral Mucositis
Currently open trials in the same condition.
- NCT07491536 — Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis · NA · recruiting
- NCT07400328 — Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients · Phase 2 · recruiting
- NCT06525402 — Effect of Sodium Bicarbonate, Saline and Black Mulberry Syrup on Degree of Oral Mucositis in Children Receiving Chemothe · NA · recruiting
- NCT06315855 — F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors) · NA · recruiting
- NCT05966194 — RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer · Phase 2 · recruiting
Other Sun Pharmaceutical Industries Limited trials
Trials by the same sponsor.
- NCT06415279 — A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients · Phase 4 · completed
- NCT06415292 — A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients · Phase 4 · completed
- NCT06336603 — A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne · Phase 4 · completed
- NCT06336629 — A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clinda · Phase 4 · completed
- NCT06415305 — A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01288625 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sun Pharmaceutical Industries Limited
- Last refreshed: 17 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01288625.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing